Assignee
HANGZHOU HEALZEN THERAPEUTICS CO LTD
CN·0 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
4 records- 0153US2025034135A1Anti-apoptotic protein bcl-2 inhibitor, pharmaceutical composition and uses thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0250US2024360146A1Bruton's tyrosine kinase and mutant degrader, composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0346US2024043430A1CRYSTAL FORM OF CASEIN KINASE 1e INHIBITOR AND PREPARATION METHOD AND USE THEREOFHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0439US2022251092A1Casein kinase 1epsilon inhibitor, pharmaceutical composition and application thereofHANGZHOU HEALZEN THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANGZHOU HEALZEN THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →